Compare Ascendis Pharma A/S (ASND) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs MasTec Inc — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while MasTec Inc trades at $277.56 (market cap $21.90B). The key difference: MasTec Inc is the larger of the two by market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals.
| ASND | MTZ | |
|---|---|---|
Market Cap | $16.67B | $21.90B |
Sector | Health | Technology |
52-Week High | $277.18 | $437.51 |
52-Week Low | $189.74 | $172.51 |
Enterprise Value | $17.04B | $24.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
